Psychedelic Depression Study - Treatment-Resistant Depression - Miami Lakes FL

Summary:

Psychedelic Depression Study - Treatment-Resistant Depression

Are you or a loved one living with Depression and currently taking antidepressant medication that doesn’t seem to help?

Segal Trials is conducting an outpatient clinical research study investigating a phase III, multi center, randomized, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two administrations of COMP360 in participants with treatment-resistant depression. 

Qualified Participants Must:

• Men and women 18 years or older
• Diagnosed with Major Depression & past medications have failed
• Currently taking an antidepressant
• Have not been diagnosed with the following: Bipolar, Schizophrenia, PTSD, OCD, Anorexia Nervosa
• Additional criteria may apply

Qualified Participants May Receive:

•Study-related exams & lab work at no cost. 

•Compensation up to $1,100 for time & travel, if qualified.

•No insurance is necessary!